Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Hepatol ; 42(6): 850-9, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15885356

ABSTRACT

BACKGROUND/AIMS: Hepatic ischemia followed by reperfusion (I/R) is a major clinical problem during transplantation, liver resection for tumor, and circulatory shock, producing apoptosis and necrosis. Although several intracellular signal molecules are induced following I/R including NF-kappaB and c-Jun N terminal kinase (JNK), their roles in I/R injury are largely unknown. The aim of this study is to assess the role of JNK during warm I/R injury using novel selective JNK inhibitors. METHODS: Male Wistar rats (200+/-25 g) are pretreated with vehicle or with one of three compounds (CC0209766, CC0223105, and CC-401), which are reversible, highly selective, ATP-competitive inhibitors of JNK. In the first study, rats are assessed for survival using a model of ischemia to 70% of the liver for 90 min followed by 30% hepatectomy of the non-ischemic lobes and then reperfusion. In the second study, rats are assessed for liver injury resulting from 60 or 90 min of ischemia followed by reperfusion with analysis over time of hepatic histology, serum ALT, hepatic caspase-3 activation, cytochrome c release, and lipid peroxidation. RESULTS: In the I/R survival model, vehicle-treated rats have a 7-day survival of 20-40%, while rats treated with the three different JNK inhibitors have survival rates of 60-100% (P<0.05). The decrease in mortality correlates with improved hepatic histology and serum ALT levels. Vehicle treated rats have pericentral necrosis, neutrophil infiltration, and some apoptosis in both hepatocytes and sinusoidal endothelial cells, while JNK inhibitors significantly decrease both types of cell death. JNK inhibitors decrease caspase-3 activation, cytochrome c release from mitochondria, and lipid peroxidation. JNK inhibition transiently blocks phosphorylation of c-Jun at an early time point after reperfusion, and AP-1 activation is also substantially blocked. JNK inhibition blocks the upregulation of the pro-apoptotic Bak protein and the degradation of Bid. CONCLUSIONS: Thus, JNK inhibitors decrease both necrosis and apoptosis, suggesting that JNK activity induces cell death by both pathways.


Subject(s)
JNK Mitogen-Activated Protein Kinases/metabolism , Liver/enzymology , Reperfusion Injury/metabolism , Animals , Apoptosis , Caspase 3 , Caspases/metabolism , Cytochromes c/metabolism , Cytoplasm/metabolism , Disease Models, Animal , Enzyme Inhibitors/pharmacology , JNK Mitogen-Activated Protein Kinases/antagonists & inhibitors , Lipid Peroxidation/drug effects , Liver/pathology , Male , Mitochondria/metabolism , Necrosis , Rats , Rats, Wistar , Reperfusion Injury/drug therapy , Reperfusion Injury/mortality , Tumor Necrosis Factor-alpha/metabolism
2.
Bioorg Med Chem Lett ; 12(9): 1307-10, 2002 May 06.
Article in English | MEDLINE | ID: mdl-11965377

ABSTRACT

A novel potent and selective aminophenol scaffold for fXa inhibitors was developed from a previously reported benzimidazole-based naphthylamidine template. The aminophenol template is more synthetically accessible than the benzimidazole template, which simplified the introduction of carboxylic acid groups. Substitution of a propenyl-para-hydroxy-benzamidine group on the aminophenol template produced selective, sub-nanomolar fXa inhibitors. The potency of the inhibitors is partially explained with the aid of a trypsin complex crystal structure.


Subject(s)
Aminophenols/chemistry , Aminophenols/chemical synthesis , Factor Xa Inhibitors , Serine Proteinase Inhibitors/chemistry , Serine Proteinase Inhibitors/chemical synthesis , X-Ray Diffraction
3.
Bioorg Med Chem Lett ; 12(9): 1311-4, 2002 May 06.
Article in English | MEDLINE | ID: mdl-11965378

ABSTRACT

Optimization of the benzimidazole-based fXa inhibitors for selectivity versus thrombin and trypsin was achieved by substitution on the benzimidazole ring and replacement of the naphthylamidine group. Substitution of a nitro group at the 4-position on the benzimidazole improves both potency against fXa and selectivity versus thrombin. Alternatively, replacement of the naphthylamidine with either a biphenylamidine or propenylbenzamidine not only improves fXa potency and selectivity versus thrombin, but selectivity versus trypsin as well.


Subject(s)
Benzimidazoles/chemistry , Factor Xa Inhibitors , Serine Proteinase Inhibitors/chemistry , Thrombin/metabolism , Trypsin/metabolism , Benzimidazoles/metabolism , Serine Proteinase Inhibitors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...